In this study, we examined the expression of Cx43 and Cx26 in a series of EWS/PNET and correlated the results with various clinicopathologic features and patient outcome in order to explore their potential role in the biology of this group of sarcomas. This evidence concerns the gene GJA1 and primitive neuroectodermal tumor.